Breaking News

Pace Life Sciences Expands CRDMO Capabilities in NH and MN

The company’s facility expansions will increase sterile fill-finish capacity and improve analytical capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace, has announced significant growth plans for two of its locations. The company’s facility expansions in Salem, NH, and Oakdale, MN, will increase sterile fill-finish capacity and improve analytical capabilities to better assist clients working on biologics, gene therapies, and other innovative molecules. “Building upon these sites gives us the ability to acceler...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters